|臨床試驗位址||7 Study Locations|
|目前研究進度||This study has been completed.|
|試驗開始日期||December 10, 2008|
|試驗開始日期||October 24, 2012|
This clinical study was planned in order to assess the superiority of INNOCELL Corp. "Immuncell-LC" in aspects of therapeutic efficacy and safety when administered with Temozolomide to glioblastoma patients when compared with the control group who did not receive administration of the drug.